| 000 | 01003 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250512200932.0 | ||
| 264 | 0 | _c19810613 | |
| 008 | 198106s 0 0 eng d | ||
| 022 | _a0305-7372 | ||
| 024 | 7 |
_a10.1016/s0305-7372(80)80041-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFefer, A | |
| 245 | 0 | 0 |
_aThe biological response modifiers (BRM) program of the National Cancer Institute. _h[electronic resource] |
| 260 |
_bCancer treatment reviews _cDec 1980 |
||
| 300 |
_a239-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferons _xtherapeutic use |
| 650 | 0 | 4 |
_aLymphokines _xtherapeutic use |
| 650 | 0 | 4 | _aNational Institutes of Health (U.S.) |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 |
_aThymus Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tCancer treatment reviews _gvol. 7 _gno. 4 _gp. 239-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0305-7372(80)80041-7 _zAvailable from publisher's website |
| 999 |
_c6163582 _d6163582 |
||